These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16705159)

  • 1. Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.
    Mazurkiewicz-Munoz AM; Argetsinger LS; Kouadio JL; Stensballe A; Jensen ON; Cline JM; Carter-Su C
    Mol Cell Biol; 2006 Jun; 26(11):4052-62. PubMed ID: 16705159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling.
    Ishida-Takahashi R; Rosario F; Gong Y; Kopp K; Stancheva Z; Chen X; Feener EP; Myers MG
    Mol Cell Biol; 2006 Jun; 26(11):4063-73. PubMed ID: 16705160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Termination of growth hormone pulse-induced STAT5b signaling.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
    Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
    Rui L; Carter-Su C
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor participates in growth hormone signaling pathway in cardiac myocytes of neonatal rat.
    Yuan G; Gu Y
    Chin Med J (Engl); 1999 Jun; 112(6):546-9. PubMed ID: 11601336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase.
    Yamauchi T; Kaburagi Y; Ueki K; Tsuji Y; Stark GR; Kerr IM; Tsushima T; Akanuma Y; Komuro I; Tobe K; Yazaki Y; Kadowaki T
    J Biol Chem; 1998 Jun; 273(25):15719-26. PubMed ID: 9624169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
    Rui L; Archer SF; Argetsinger LS; Carter-Su C
    J Biol Chem; 2000 Jan; 275(4):2885-92. PubMed ID: 10644756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
    Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
    Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
    King AP; Carter-Su C
    Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.
    Argetsinger LS; Kouadio JL; Steen H; Stensballe A; Jensen ON; Carter-Su C
    Mol Cell Biol; 2004 Jun; 24(11):4955-67. PubMed ID: 15143187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.